XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 40.59

Change

+0.30 (+0.74)%

Market Cap

CAD 0.45B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-13 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

+1.02 (+0.72%)

CAD 18.40B
ZSP:CA BMO S&P 500

+0.58 (+0.67%)

CAD 16.97B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+0.72 (+1.21%)

CAD 11.11B
VUN:CA Vanguard US Total Market

+0.87 (+0.82%)

CAD 10.08B
XUS:CA iShares Core S&P 500 Index ETF

+0.39 (+0.79%)

CAD 7.80B
HXS:CA Global X S&P 500 Corporate Cla..

+0.56 (+0.69%)

CAD 4.30B
VSP:CA Vanguard S&P 500 CAD hedged

+1.15 (+1.24%)

CAD 3.59B
QUU:CA Mackenzie US Large Cap Equity ..

+1.74 (+0.76%)

CAD 3.40B
XUU:CA iShares Core S&P US Total Mark..

+0.44 (+0.75%)

CAD 3.20B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

+0.66 (+1.32%)

CAD 3.15B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.45% 88% B+ 82% B
Dividend Return 0.50% 19% F 15% F
Total Return 21.96% 90% A- 81% B-
Trailing 12 Months  
Capital Gain 26.65% 73% C 79% B-
Dividend Return 1.16% 27% F 25% F
Total Return 27.81% 81% B- 78% C+
Trailing 5 Years  
Capital Gain 91.19% 81% B- 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 91.19% 74% C 84% B
Average Annual (5 Year Horizon)  
Capital Gain 13.65% 78% C+ 80% B-
Dividend Return 14.44% 78% C+ 78% C+
Total Return 0.79% 20% F 33% F
Risk Return Profile  
Volatility (Standard Deviation) 14.38% 44% F 56% F
Risk Adjusted Return 100.44% 71% C- 97% N/A
Market Capitalization 0.45B 53% F 58% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.